Insights into hemolytic uremic syndrome:: Segregation of three independent predisposition factors in a large, multiple affected pedigree

被引:105
作者
Esparza-Gordillo, J
de Jorge, EG
Garrido, CA
Carreras, L
López-Trascasa, M
Sánchez-Corral, P
de Córdoba, SR
机构
[1] CSIC, Ctr Invest Biol, Madrid 28040, Spain
[2] Hosp Univ La Paz, Unidad Invest, Madrid 28046, Spain
[3] Hosp Univ Bellvitge, Serv Nefrol, Barcelona 08907, Spain
[4] Hosp Univ La Paz, Unidad Inmunol, Madrid 28046, Spain
关键词
membrane cofactor protein; atypical hemolytic uremic syndrome; complement factor I;
D O I
10.1016/j.molimm.2005.11.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the complement regulators factor H, membrane cofactor protein (MCP), and factor I are associated with atypical hemolytic uremic syndrome (aHUS, MIM 235400), suggesting that the disease develops as a consequence of the inefficient protection of the renal endothelium from damage by the complement system. Incomplete penetrance of the disease in individuals carrying these mutations is, however, relatively frequent. Here, we report the identification of a large, multiple affected aHUS pedigree in which there is independent segregation of three different aHUS risk factors: a MCP missense mutation (c.-598C > T; Pro 165Ser) that decreases MCP expression on the cell surface, a dinucleotide insertion in the coding sequence of factor I (c.- 1610insAT) that introduces a premature stop codon in the factor I protein, and the MCPggaac SNP haplotype block that was previously shown to decrease the transcription activity from the MCP promoter. Interestingly, individuals affected by aHUS in the pedigree are only those who have inherited the three aHUS risk factors. These data show an additive effect for mutations in MCP and factor I and provide definitive support to the conclusion that aHUS results from a defective protection of cellular surfaces from complement activation. Furthermore, they help to explain the incomplete penetrance of the disease, illustrating that concurrence of multiple hits in complement regulatory proteins may be necessary to significantly impair host tissue protection and to confer susceptibility to aHUS. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1769 / 1775
页数:7
相关论文
共 22 条
[1]   Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease [J].
Caprioli, J ;
Castelletti, F ;
Bucchioni, S ;
Bettinaglio, P ;
Bresin, E ;
Pianetti, G ;
Gamba, S ;
Brioschi, S ;
Daina, E ;
Remuzzi, G ;
Noris, M .
HUMAN MOLECULAR GENETICS, 2003, 12 (24) :3385-3395
[2]  
Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297
[3]  
CUI WI, 1993, J IMMUNOL, V151, P4137
[4]   The human complement factor H:: functional roles, genetic variations and disease associations [J].
de Córdoba, SR ;
Esparza-Gordillo, J ;
de Jorge, EG ;
Lopez-Trascasa, M ;
Sánchez-Corral, P .
MOLECULAR IMMUNOLOGY, 2004, 41 (04) :355-367
[5]   Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32 [J].
Esparza-Gordillo, J ;
de Jorge, EG ;
Buil, A ;
Berges, LC ;
López-Trascasa, M ;
Sánchez-Corral, P ;
de Córdoba, SR .
HUMAN MOLECULAR GENETICS, 2005, 14 (05) :703-712
[6]   Genetic and environmental factors influencing the human factor H plasma levels [J].
Esparza-Gordillo, J ;
Soria, JM ;
Buil, A ;
Almasy, L ;
Blangero, J ;
Fontcuberta, J ;
de Córdoba, SR .
IMMUNOGENETICS, 2004, 56 (02) :77-82
[7]   Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome [J].
Fremeaux-Bacchi, V ;
Dragon-Durey, MA ;
Blouin, J ;
Vigneau, C ;
Kuypers, D ;
Boudailliez, B ;
Loirat, C ;
Rondeau, E ;
Fridman, WH .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (06) :e84
[8]  
FREMEAUXBACCHI V, 2005, J MED GENET
[9]   Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation [J].
González-Rubio, C ;
Ferreira-Cerdán, A ;
Ponce, IM ;
Arpa, J ;
Fontán, G ;
López-Trascasa, M .
ARCHIVES OF NEUROLOGY, 2001, 58 (11) :1923-1928
[10]   Infection by shiga toxin-producing Escherichia coli -: An overview [J].
Karmali, MA .
MOLECULAR BIOTECHNOLOGY, 2004, 26 (02) :117-122